Dermata Therapeutics, Inc. DRMA 深 滬
等待開盤 07-19 09:30:00 美东时间
0.679
-0.004
-0.59%
華盛通- 最 高0.7069
- 今 開0.6848
- 成交量 4.73万股
- 最 低 0.6539
- 昨 收 0.683
- 總市值 433.07万
- 52周最高 3.79
- 市盈率 靜 --
- 換手率 0.74%
- 52周最低 0.5739
- 委 比 -60.00%
- 總股本 637.81万
- 歷史最高 1668.00
- 量 比 0.55
- 振 幅 7.76%
- 歷史最低 0.5739
- 每 手 1
- 風險率 0.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Australian Patent Office Dermata Therapeutics Patent Application For DMT410 Program For Hyperhidrosis Titled "Compositions for the treatment of skin conditions," (Australian Patent No. 2109284621)
- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Collaboration
07-08 20:11
Dermata Faces Nasdaq Delisting Risk, Plans Stock Split
Dermata Therapeutics ( ($DRMA) ) has issued an announcement. On May 14, 2025, D...
07-08 05:49
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 50.4% to $5.2 dur...
07-08 05:06
Maxim Group Maintains Buy on Dermata Therapeutics, Lowers Price Target to $3
Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target from $6 to $3.
05-21 22:51
Dermata Therapeutics Begins Manufacturing for STAR-2 Trial
Dermata Therapeutics ( ($DRMA) ) has provided an update. On May 20, 2025, Derma...
05-21 21:31
Dermata Reports Positive Phase 3 Trial Results
Dermata Therapeutics ( ($DRMA) ) just unveiled an update. In the first quarter ...
05-14 21:30
Nano-Cap Dermata Therapeutics Unveils Positive Data From Once Weekly Drug Study For Acne
Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half of 2025.
03-27 22:21
BREAKING: Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints
- XYNGARI™ achieved its primary endpoints, demonstrating highly statistically significant and clinically meaningful improvement in acne - - XYNGARI™ is the first once-weekly topical product ...
03-27 20:00
Terns Pharmaceuticals盘中异动 下午盘急速下挫5.04%
北京时间2025年02月12日02时50分，Terns Pharmaceuticals, Inc.（TERN.us）股票出现波动，股价快速下跌5.04%。截至发...
02-12 02:50
